Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Doceree
AddedFeb 15, 2024
UpdatedJun 18, 2026
Doceree

Doceree

Series B

Doceree: The first global network for programmatic healthcare marketing, exclusive to physicians.

HQ
Parsippany-Troy Hills, NJ, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize healthcare marketing, Doceree is the first global network dedicated to programmatic marketing exclusively for physicians. The company offers a suite of products powered by its proprietary identity-resolution technology, ESPYIANTM, which enables hyper-targeted advertising to healthcare professionals (HCPs). Doceree's platform facilitates efficient, measurable, and trusted advertising through direct platform reach, consumer advertising networks, and private marketplaces, focusing on creating highly specific and engaged audiences.

Notable figures associated with Doceree include industry experts and investors who have recognized the potential of programmatic healthcare marketing. The company has achieved significant milestones in developing proprietary data tools that enhance the precision and effectiveness of HCP-targeted campaigns. By providing unprecedented solutions in the healthcare marketing space, Doceree has made a substantial impact on how pharmaceutical and healthcare brands connect with physicians, ultimately improving the efficiency and effectiveness of healthcare communications.

Doceree - Similar Companies

DocMatter logo

DocMatter

docmatter.com

Docus logo

Docus

docus.ai

DocDelta logo

DocDelta

docdelta.com

H1 logo

H1

h1.co

Impiricus logo

Impiricus

impiricus.com

engageSimply logo

engageSimply

engagesimply.com

SocialClimb logo

SocialClimb

socialclimb.com

Doctible logo

Doctible

doctible.com

Doximity logo

Doximity

doximity.com

Doc.com logo

Doc.com

MedRank logo

MedRank

Docty logo

Docty

docty.ai

MedScout logo

MedScout

medscout.io

HeyDoc! logo

HeyDoc!

heydoc.net

GetDoctor logo

GetDoctor

getdoctor.co

Doceree - Quick Facts

Who are Doceree's competitors?

Companies similar to Doceree include DocMatter, Docus, DocDelta and H1.

When was Doceree founded?

Doceree was founded in 2019.

Where is Doceree's headquarters located?

Doceree's headquarters is located in Parsippany-Troy Hills, NJ, US.

When was Doceree's last funding round?

Doceree's most recent funding round was for $35M (USD) in September 2023.

How much has Doceree raised to-date?

As of Sep 27, 2023, Doceree has raised a total of $47M (USD).

How many employees does Doceree have?

Doceree has 107 employees as of Feb 5, 2024.

Doceree - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Advertising
Customer
  • Enterprise
Main Product
  • Healthcare Marketing
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services
  • 541600Management, Scientific, and Technical Consulting Services
  • 541610Management Consulting Services
  • 541613Marketing Consulting Services
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8740Management And Public Relations Services
  • 8742Management Consulting Services
Show 11 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 541800Advertising, Public Relations, and Related Services
  • 513210Software Publishers
  • 541810Advertising Agencies
SIC
  • 7300Business Services
  • 7310Advertising
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7311Advertising Agencies
  • 7372Prepackaged Software